DBV Technologies | Passifs Courants



Current Liabilities Changement Date
Acadia Pharmaceuticals USD 330.02M 27.49M 2025-06
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amarin USD 162.41M 17.54M 2025-03
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
DBV Technologies USD 49.42M 9.04M 2025-06
Halozyme Therapeutics USD 134.28M 16.1M 2025-06
Incyte USD 1.28B 608.18M 2025-06
Insmed USD 311.68M 72.45M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
PTC Therapeutics USD 627.81M 32.42M 2025-06
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
Ultragenyx Pharmaceutical USD 293.24M 1.58M 2025-06
United Therapeutics USD 527.1M 194.4M 2025-06


DBV Technologies Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.